Rudi Scheerlinck | Global Head Pharmacovigilance Risk Management
Nestle Skin Health

Rudi Scheerlinck, Global Head Pharmacovigilance Risk Management, Nestle Skin Health


Day Two World Drug Safety Congress EU 2018 @ 15:20

Drug safety in children

  • Specificities to take into account when performing signal detection in children
  • Importance of data entry on the results of signal detection
  • Importance of the disease
last published: 04/Sep/18 15:35 GMT

back to speakers